Fortress Biotech, Inc. Other Non-Current Liabilities
Fortress Biotech, Inc. (FBIO) had Other Non-Current Liabilities of $2.54 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-13
- 2026-06-30: Other Liabilities, Noncurrent $2.54M.
- 2026-03-31: Other Liabilities, Noncurrent $2.20M.
- 2025-12-31: Other Liabilities, Noncurrent $1.45M.
- 2025-09-30: Other Liabilities, Noncurrent $1.62M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $2.54M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.20M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $1.45M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.62M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.66M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.71M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.76M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.75M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.80M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.85M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.89M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.71M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.75M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.80M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.85M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $1.89M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.94M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.99M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.03M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $2.08M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.86M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $1.90M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.95M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $8.21M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $7.34M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $7.23M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $2.14M 10-K/A · filed 2021-04-09 | $7.13M 10-K · filed 2020-03-16 |
| 2019-09-30 | $7.03M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $2.23M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $2.28M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $5.21M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $4.96M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $4.99M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $4.76M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $4.74M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $4.74M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $5.03M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $5.02M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $5.01M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $4.58M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $3.71M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $2.42M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $584.00K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $202.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $264.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $327.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $722.00K 10-K · filed 2016-03-15 | |
| 2014-09-30 | $793.00K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $754.00K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $1.07M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $1.08M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $1.54M 10-Q · filed 2013-11-01 | |
| 2012-12-31 | $1.44M 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |